Palisade Bio (PALI) Receivables - Net (2011 - 2023)

Palisade Bio (PALI) reported Receivables - Net of $300000.0 for Q1 2023, up 408.47% quarter-over-quarter from $59000.0 in Q2 2021.

Palisade Bio (PALI) Receivables - Net (2011 - 2023) Analysis & Trends

Palisade Bio (PALI) has 12 years of Receivables - Net data on file, last reported at $300000.0 in Q1 2023.

  • Receivables - Net for Q1 2023 came in at $300000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $300000.0 (changed N/A YoY), and the FY2020 annual result was $59000.0, up 180.1% from the prior year.
  • Receivables - Net improved to $300000.0 in Q1 2023 per PALI's latest filing, from $59000.0 in the prior quarter.
  • Over five years, Receivables - Net peaked at $300000.0 in Q1 2023 and troughed at $8779.0 in Q3 2020.
  • A 4-year average of $88899.5 and a median of $59000.0 in 2020 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2019 and 2021: Receivables - Net plunged 92.84% in 2019, then jumped 248.33% in 2021.
  • A 4-year view of Receivables - Net shows it stood at $21064.0 in 2019, then soared by 180.1% to $59000.0 in 2020, then changed by 0.0% to $59000.0 in 2021, then soared by 408.47% to $300000.0 in 2023.
  • Business Quant data shows PALI's Receivables - Net at $300000.0 in Q1 2023, $59000.0 in Q2 2021, and $25259.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Palisade Bio 391.02 Mn 261.45 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 300,000.00
Mar 31, 2023 300,000.00
Jun 30, 2021 59,000.00
Jun 30, 2021 59,000.00
Mar 31, 2021 25,259.00
Mar 31, 2021 25,259.00
Dec 31, 2020 59,000.00
Dec 31, 2020 59,000.00
Sep 30, 2020 8,779.00
Sep 30, 2020 8,779.00
Jun 30, 2020 16,938.00
Jun 30, 2020 16,938.00
Mar 31, 2020 19,014.00
Mar 31, 2020 19,014.00
Dec 31, 2019 21,064.00
Dec 31, 2019 21,064.00
Sep 30, 2019 61,154.00
Sep 30, 2019 61,154.00
Jun 30, 2019 169,905.00
Jun 30, 2019 169,905.00